Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00006708. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT07283796. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment
ClinicalTrials.gov study NCT07275216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma
ClinicalTrials.gov study NCT00305149. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma
ClinicalTrials.gov study NCT00512980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06381830. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab Plus MG4101 Indolent CD20-positive Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT03578198. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00094848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment
ClinicalTrials.gov study NCT00881387. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant
ClinicalTrials.gov study NCT01959477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma
ClinicalTrials.gov study NCT00498667. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01701232. IPD Sharing: NO. Countries: 5. Publications: 0.
Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
ClinicalTrials.gov study NCT05407480. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00864942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00062296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial
ClinicalTrials.gov study NCT03003546. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Lenalidomide With or Without Rituximab and Other Drugs in B-cell Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT04435743. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Camrelizumab Plus Decitabine in Anti-PD-1 Treatment-naive Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT04510610. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1)
ClinicalTrials.gov study NCT05844956. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae
ClinicalTrials.gov study NCT01010295. IPD Sharing: Not stated. Countries: 4. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.